Haptoglobin polymorphism in Korean patients with cardiovascular diseases

Area of Science:

• Genetics
• Cardiovascular Science
• Biochemistry

Background:

• Hepatoglobin (Hp) is a protein involved in various biological processes.
• Hp polymorphism, variations in the Hp gene, has been studied for its potential role in disease susceptibility.
• Understanding the relationship between Hp and cardiovascular disease (CVD) is crucial for public health.

Purpose of the Study:

• To investigate the association between hepatoglobin (Hp) polymorphism and plasma lipid levels in a Korean population.
• To determine if Hp phenotypes are linked to the risk of developing cardiovascular disease.
• To explore age-related differences in Hp allele frequencies.

Main Methods:

• Analysis of hepatoglobin (Hp) phenotypes in 913 Korean subjects.
• Comparison of Hp phenotype distribution between healthy controls and cardiovascular disease patients.
• Assessment of plasma lipid levels, including high-density lipoprotein cholesterol.
• Evaluation of Hp*1 allele frequency in different age subgroups.

Main Results:

• No significant difference in Hp phenotype distribution was observed between healthy controls and cardiovascular disease patients.
• A higher Hp*1 allele frequency was found in healthy individuals aged 50 and older compared to younger individuals (p < 0.005).
• Hp phenotypes were significantly associated with high-density lipoprotein cholesterol levels in the hypertensive patient group.

Conclusions:

• Hepatoglobin (Hp) polymorphism does not appear to predispose individuals to cardiovascular diseases in the Korean population.
• Age-related increases in Hp*1 allele frequency in healthy individuals warrant further investigation.
• Hp phenotypes may influence lipid metabolism, specifically high-density lipoprotein cholesterol, in hypertensive individuals.